Rubén Cabanillas1, Juan Pablo Rodrigo, Jose Luis Llorente, Carlos Suárez. 1. Departament of Otorhinolaryngology, Hospital Universitario Central de Asturias, and Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Oviedo, Spain. rcabanillas@telecable.es
Abstract
BACKGROUND: To evaluate the oncologic effectiveness of transoral laser surgery of supraglottic cancer, we compared a group of patients treated with laser surgery, with a stage-matched group treated with a transcervical approach. METHODS: Twenty-six patients who underwent laser surgery were retrospectively compared with 26 patients who underwent a transcervical approach. In both groups, the patients were classified as follows: 8% stage I, 23% stage II, 46% stage III, and 23% stage IV. RESULTS: The 5-year disease-specific survival rates were 80% for the laser group and 72% for the transcervical group (p = .5). The ultimate 5-year laryngeal preservation rate was 86% in the laser group and 80% in the transcervical group (p = .6). In both arms, all patients classified as T1 and T2 who survived 5 years after the surgical treatment of tumors retained the larynx. CONCLUSIONS: The oncologic results of transoral laser surgery of supraglottic cancer are equivalent to those of the classic transcervical approach.
BACKGROUND: To evaluate the oncologic effectiveness of transoral laser surgery of supraglottic cancer, we compared a group of patients treated with laser surgery, with a stage-matched group treated with a transcervical approach. METHODS: Twenty-six patients who underwent laser surgery were retrospectively compared with 26 patients who underwent a transcervical approach. In both groups, the patients were classified as follows: 8% stage I, 23% stage II, 46% stage III, and 23% stage IV. RESULTS: The 5-year disease-specific survival rates were 80% for the laser group and 72% for the transcervical group (p = .5). The ultimate 5-year laryngeal preservation rate was 86% in the laser group and 80% in the transcervical group (p = .6). In both arms, all patients classified as T1 and T2 who survived 5 years after the surgical treatment of tumors retained the larynx. CONCLUSIONS: The oncologic results of transoral laser surgery of supraglottic cancer are equivalent to those of the classic transcervical approach.
Authors: Soon-Hyun Ahn; Hyun Jun Hong; Soon Young Kwon; Kee Hwan Kwon; Jong-Lyel Roh; Junsun Ryu; Jun Hee Park; Seung-Kuk Baek; Guk Haeng Lee; Sei Young Lee; Jin Choon Lee; Man Ki Chung; Young Hoon Joo; Yong Bae Ji; Jeong Hun Hah; Minsu Kwon; Young Min Park; Chang Myeon Song; Sung-Chan Shin; Chang Hwan Ryu; Doh Young Lee; Young Chan Lee; Jae Won Chang; Ha Min Jeong; Jae-Keun Cho; Wonjae Cha; Byung Joon Chun; Ik Joon Choi; Hyo Geun Choi; Kang Dae Lee Journal: Clin Exp Otorhinolaryngol Date: 2017-01-03 Impact factor: 3.372
Authors: Rocío González-Márquez; Juan P Rodrigo; Jose Luis Llorente; Cesar Alvarez-Marcos; Juan P Díaz; Carlos Suárez Journal: Eur Arch Otorhinolaryngol Date: 2012-04-07 Impact factor: 2.503